Hutch News

Hutch News

Stories tagged 'Immunology Program'

Tailoring immune cells to target leukemia

Promising early trial results show engineered immune cells may help buffer against cancer relapse after bone marrow transplantation

April 21, 2016 | By Sabrina Richards / Fred Hutch News Service

Dr. Phil Greenberg’s team at Fred Hutch has developed methods to genetically modify T cells, a type of immune cell, to specifically seek out cancer cells while they ignore healthy cells. On Wednesday, he presented results of an early-stage trial at the American Association for Cancer Research annual conference in New Orleans that appear to show promise in preventing disease relapse after blood stem cell transplantation.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

April 21, 2016

Women’s Health Initiative receives AACR Team Science Award; Andrew Hsieh awarded AACR NextGen Grant for Transformative Cancer Research; Designing an off-the-shelf nanoparticle-based immunotherapy; Fred Hutch’s Vaccine and Infectious Disease Division contributes to early study of promising Ebola vaccine

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.